Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal

• The optimal antithrombotic regimen to be used in patients with AF and PCI or ACS is still debated. • Each of the six randomised controlled trials comparing double to triple therapy has limitations. • None was powered to assess differences between treatment arms in ischaemic event rates. • The cont...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cardiol Heart Vasc
Autori principali: Galli, Mattia, Andreotti, Felicita, D'Amario, Domenico, Vergallo, Rocco, Montone, Rocco A., Niccoli, Giampaolo, Crea, Filippo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229495/
https://ncbi.nlm.nih.gov/pubmed/32435688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100524
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi